메뉴 건너뛰기
Journal of the American Academy of Dermatology
Volumn 59, Issue 2 SUPPL., 2008, Pages
Intertriginous and follicular eruption to anticytotoxic T-lymphocyte antigen 4 monoclonal antibody
Author keywords

[No Author keywords available]
Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GLYCOPROTEIN; PEPTIDE VACCINE; PREDNISONE;
EID: 46749155848     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.07.022     Document Type: Article
Times cited : (5)
References (4)
  • 1
    • 0344341626 scopus 로고    scopus 로고
    • Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
    • Hodi F.S., Mihm M.C., Soiffer R.J., Haluska F.G., Butler M., Seiden M.V., et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A 100 (2003) 4712-4717
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 4712-4717
    • Hodi, F.S.1    Mihm, M.C.2    Soiffer, R.J.3    Haluska, F.G.4    Butler, M.5    Seiden, M.V.6
  • 2
    • 0038153907 scopus 로고    scopus 로고
    • Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
    • Phan G.Q., Yang J.C., Sherry R.M., Hwu P., Topalian S.L., Schwartzentruber D.J., et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A 100 (2003) 8372-8377
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 8372-8377
    • Phan, G.Q.1    Yang, J.C.2    Sherry, R.M.3    Hwu, P.4    Topalian, S.L.5    Schwartzentruber, D.J.6
  • 3
    • 20044395957 scopus 로고    scopus 로고
    • Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and montanide ISA 51 for patients with resected stages III and IV melanoma
    • Sanderson K., Scotland R., Lee P., Liu D., Groshen S., Snively J., et al. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and montanide ISA 51 for patients with resected stages III and IV melanoma. J Clin Oncol 23 (2005) 741-750
    • (2005) J Clin Oncol , vol.23 , pp. 741-750
    • Sanderson, K.1    Scotland, R.2    Lee, P.3    Liu, D.4    Groshen, S.5    Snively, J.6
  • 4
    • 33244458474 scopus 로고    scopus 로고
    • Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent
    • Jaber S.H., Cowen E.W., Haworth L.R., Booher S.L., Berman D.M., Rosenberg S.A., et al. Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent. Arch Dermatol 142 (2006) 166-172
    • (2006) Arch Dermatol , vol.142 , pp. 166-172
    • Jaber, S.H.1    Cowen, E.W.2    Haworth, L.R.3    Booher, S.L.4    Berman, D.M.5    Rosenberg, S.A.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.